| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.28 | 0.2 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |